COMMUNIQUÉS West-GlobeNewswire

PROPHASE LABS, INC. ANNOUNCES COMPLETION OF IMPORTANT NEXT STEP FOR CROWN MEDICAL COLLECTIONS $50 MILLION A/R INITIATIVE
23/09/2025
COVID-19 TESTING LABORATORY SUBSIDIARIES FILE FOR BANKRUPCTY PROTECTION UNIONDALE, NY, Sept. 23, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase” or the “Company”), a next generation biotech, [...]
Amneal Receives U.S. FDA Approval for Bimatoprost Ophthalmic Solution, 0.01%
23/09/2025
Important ophthalmic treatment for patients and expected to be a key growth driver for Amneal’s Affordable Medicines segment BRIDGEWATER, N.J., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (“Amneal” [...]
Vanderbilt Report: Full Alliance Group helps Power Hypochlorous Acid’s Breakout from Hospitals to the Global Consumer Market
23/09/2025
BRISTOL, Tenn., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Once relegated to the back rooms of hospitals, hypochlorous acid (HOCl) is rapidly becoming one of the most disruptive platform chemicals of the decade and Full [...]
Reviva to Participate in the Lytham Partners Fall 2025 Investor Conference
23/09/2025
CUPERTINO, Calif., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that seek to address unmet [...]
ALPINE WHITE brings Brazil its first peroxide-free dental whitening strips
23/09/2025
Swiss oral-care brand launches a clinically tested at-home whitening range, now available at leading pharmacy chains nationwide RIO DE JANEIRO, Sept. 23, 2025 (GLOBE NEWSWIRE) -- ALPINE WHITE , the Swiss oral-care [...]
InnovAge Appoints Meredith Delk as Executive Vice President and Chief Administrative Officer
23/09/2025
DENVER, Sept. 23, 2025 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (“InnovAge” or the “Company”) (Nasdaq: INNV), an industry leader in providing comprehensive healthcare programs to frail, predominantly dual-eligible [...]
Myriad Genetics and SOPHiA GENETICS to Develop an Innovative Companion Diagnostic Offering in Liquid Biopsy
23/09/2025
SALT LAKE CITY and BOSTON, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics (Nasdaq: MYGN), a leader in molecular diagnostic testing and precision medicine, and SOPHiA GENETICS (Nasdaq: SOPH), an AI technology company [...]
Izotropic’s IzoView Breast CT the First in Category to Offer Patent-Pending Personalized Radiation Dose
23/09/2025
- Patent-pending pre-scan technology enables custom radiation dose tailored to patient’s unique breast size and composition - - Feature aligns with personalized medicine trends driving the global breast imaging device [...]
Daxor Corporation Unveils Breakthrough Next-Gen BVA Analyzer at HFSA Annual Scientific Meeting
23/09/2025
Additional New Clinical Data To Be Presented Driving a New Standard of Care in Volume Measurement OAK RIDGE, Tenn., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume [...]
Hydrafacial Joins Cosmopolitan Readers’ Choice Hall of Fame as Three-Time Winner for Best Pro Facial
23/09/2025
This accolade builds on a year of major awards, reinforcing Hydrafacial’s proven results and trusted position with consumers and providers worldwide LONG BEACH, Calif., Sept. 23, 2025 (GLOBE NEWSWIRE) -- The Beauty [...]
Texas Prostate and Dallas Medical Center Launch First-of-its-Kind TULSA Program, Expanding Access to Advanced Prostate Treatment
23/09/2025
New program delivers TULSA Procedure’s precision treatment - minimal side effects, no overnight hospital stay – to Medicare patients across Texas TORONTO, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. ( [...]
Vanderbilt Report: Coeptis Shows How Biotech Can Fund Itself While Innovating
23/09/2025
COEP Balances Revenue Generation With Breakthrough Cell Therapy Development BRISTOL, Tenn., Sept. 23, 2025 (GLOBE NEWSWIRE) -- VanderbiltReport.com , a financial news and content platform, reports that Coeptis [...]
Solid Biosciences Announces Licensing Agreement with Kinea Bio for the Use of Proprietary Next-Generation Capsid AAV-SLB101
23/09/2025
- Non-exclusive license for Solid’s proprietary, next generation capsid, AAV-SLB101, to accelerate development of Kinea Bio’s gene therapy for dysferlin-related limb-girdle muscular dystrophy - - Solid to receive an [...]
Santhera Announces Half Year 2025 Financial Results and Provides Corporate Update
23/09/2025
Ad hoc announcement pursuant to Art. 53 LR A conference call will be held on September 23, 2025, at 14:00 CEST / 13:00 BST / 08:00 EDT. Details are at the end of this news release Pratteln, Switzerland, September 23, [...]
Labviva Kicks Off Smart Lab of the Future Tour
23/09/2025
Life sciences procurement leader showcases AI-driven supply chain innovation at global events BOSTON, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Labviva , the leading AI-powered procurement platform for life sciences, today [...]
Santhera Secures CHF 20 Million Growth Funding to Accelerate Global AGAMREE® Rollout
23/09/2025
Ad hoc announcement pursuant to Art. 53 LR Highlights: Santhera secures approximately CHF 20 million of additional funding from existing investors Highbridge and R-Bridge to accelerate global rollout Demand for AGAMREE [...]
Communiqué de presse : La thérapie SAR446268 de Sanofi obtient son admission dans la procédure accélérée américaine pour le traitement de la dystrophie myotonique non congénitale de type 1
23/09/2025
La thérapie SAR446268 de Sanofi obtient son admission dans la procédure accélérée américaine pour le traitement de la dystrophie myotonique non congénitale de type 1 Admission obtenue pour la thérapie génique AAV unique [...]
Press Release: Sanofi’s SAR446268 earns US fast track designation for the treatment of non-congenital myotonic dystrophy type 1
23/09/2025
Sanofi’s SAR446268 earns US fast track designation for the treatment of non-congenital myotonic dystrophy type 1 Designation earned for one-time AAV gene therapy SAR446268, designed to silence DMPK expression Myotonic [...]
Addex Appoints Bank of New York Mellon as Depositary Bank
23/09/2025
Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, September 23, 2025 - Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small [...]

Pages